Login / Signup

Incidence of metabolic bone disease in neonates under 32 gestational weeks at the Hospital Universitario de Santander in Colombia.

Erika RuizDiego Ernesto PiamonteDeisy Tatiana GómezLuis Alfonso Díaz-MartínezLuis Alfonso Pérez
Published in: Biomedica : revista del Instituto Nacional de Salud (2024)
Establishing an early intervention in patients with metabolic bone disease enhancing risk factors, such as low weight and prolonged parenteral nutrition, is critical to prevent severe complications.
Keyphrases
  • risk factors
  • weight gain
  • bone mineral density
  • randomized controlled trial
  • healthcare
  • pregnant women
  • body mass index
  • soft tissue
  • weight loss
  • body composition
  • adverse drug
  • preterm infants